Ofloxacin

Publication Title: 
British Journal of Urology

OBJECTIVE: To report changes in the white blood cell (WBC) counts in expressed prostatic secretions (EPS) in men with pelvic symptoms undergoing thrice-weekly prostatic massage combined with antimicrobial therapy.

Author(s): 
Hennenfent, B. R.
Feliciano, A. E.
Publication Title: 
International Braz J Urol: Official Journal of the Brazilian Society of Urology

INTRODUCTION: The exact mechanism of chronic nonbacterial prostatitis has not been yet elucidated and the outcome with the current management is dismal. In this trial, we studied the effect of allopurinol in the treatment of this disease. MATERIALS AND METHODS: In this randomized double blind controlled trial, a calculated sample size of 56 were grouped into "intervention group" who received allopurinol (100 mg tds for 3 months) with ofloxacin (200 mg tds) for 3 weeks (n = 29) and "control group" who received placebo tablets with ofloxacin (n = 27).

Author(s): 
Ziaee, Amir M.
Akhavizadegan, Hamed
Karbakhsh, Mojgan
Publication Title: 
Prostate Cancer and Prostatic Diseases

We investigated the effect of prostatic inflammation on prostate-specific antigen (PSA) and per cent-free PSA levels changing after antibacterial therapy. We evaluated 48 patients whose PSA levels were between 4 and 10 ng/ml, without any suspicious findings on digital rectal examination, with no infection findings in urine analysis. Prostatic inflammation was assessed with prostatic massage. All the patients were given antibiotic therapy for 3 weeks. Patients were re-evaluated 3 weeks after antibacterial therapy with PSA (free/total) and urinalysis.

Author(s): 
Kaygisiz, O.
Uğurlu, O.
Koşan, M.
Inal, G.
Oztürk, B.
Cetinkaya, M.
Publication Title: 
The Journal of International Medical Research

The efficacy of tamsulosin in the treatment of chronic non-bacterial prostatitis was evaluated in a randomized clinical observation of 105 male outpatients conducted for 90 days. Patients were randomly divided into five groups (n = 21 per group) according to prostatitis type IIIA or IIIB and therapy regimens (tamsulosin, levofloxacin, or tamsulosin plus levofloxacin combination therapy).

Author(s): 
Ye, Z. Q.
Lan, R. Z.
Yang, W. M.
Yao, L. F.
Yu, X.
Publication Title: 
Andrologia

To investigate the association between eradication of Chlamydia trachomatis (CT) and symptom regression in chronic prostatitis, 55 symptomatic patients were subjected to segmented tests to localise CT in first voided urine (VB1), prostatic secretions (EPS), post-massage voided (VB3) or semen specimens. Patients were divided in three treatment groups: the 'urethral involvement' group ('U': VB1 positive, EPS/VB3/Semen negative) was treated with 500 mg day(-1) azithromycin for 3 days.

Author(s): 
Magri, V.
Marras, E.
Skerk, V.
Markotić, A.
Restelli, A.
Garlaschi, M. C.
Perletti, G.
Publication Title: 
Antimicrobial Agents and Chemotherapy

The effects of single coadministrations of one of three traditional Chinese medicines, Hotyu-ekki-to, Rikkunshi-to, and Juzen-taiho-to, on the pharmacokinetics of levofloxacin (LVFX) were investigated with eight healthy volunteers in an open, random crossover fashion. Subjects each received a single oral dose of LVFX (200 mg) alone and then with a single coadministration of each Chinese medicine. There were no significant differences in any pharmacokinetic parameters of LVFX between the groups.

Author(s): 
Hasegawa, T.
Yamaki, K.
Muraoka, I.
Nadai, M.
Takagi, K.
Nabeshima, T.
Subscribe to RSS - Ofloxacin